These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
407 related items for PubMed ID: 9305480
1. Age-dependent eradication of Helicobacter pylori with dual therapy. Treiber G, Ammon S, Klotz U. Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480 [Abstract] [Full Text] [Related]
2. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study). Treiber G, Wittig J, Ammon S, Walker S, van Doorn LJ, Klotz U. Arch Intern Med; 2002 Jan 28; 162(2):153-60. PubMed ID: 11802748 [Abstract] [Full Text] [Related]
3. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer]. Kayser S, Flury R, Zbinden R, Fried M, Wirth HP. Schweiz Med Wochenschr; 1997 Apr 26; 127(17):722-7. PubMed ID: 9221483 [Abstract] [Full Text] [Related]
5. High-dose proton pump inhibitor plus amoxycillin for the treatment or retreatment of Helicobacter pylori infection. Malaty H, el-Zimaity HM, Genta RM, Cole RA, Graham DY. Aliment Pharmacol Ther; 1996 Dec 26; 10(6):1001-4. PubMed ID: 8971301 [Abstract] [Full Text] [Related]
6. Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication. Spadaccini A, De Fanis C, Sciampa G, Russo L, Silla M, Pantaleone U, Di Virgilio M, Pizzicanella G. Aliment Pharmacol Ther; 1998 Oct 26; 12(10):997-1001. PubMed ID: 9798805 [Abstract] [Full Text] [Related]
7. One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication. Gisbert JP, Carpio D, Marcos S, Gisbert JL, García Grávalos R, Pajares JM. Eur J Gastroenterol Hepatol; 2000 May 26; 12(5):489-95. PubMed ID: 10833090 [Abstract] [Full Text] [Related]
8. Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection. Harford W, Lanza F, Arora A, Graham D, Haber M, Weissfeld A, Rose P, Siepman N. Helicobacter; 1996 Dec 26; 1(4):243-50. PubMed ID: 9398875 [Abstract] [Full Text] [Related]
9. Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin. Louw JA, Van Rensburg CJ, Moola S, Kotze D, Marks IN. Aliment Pharmacol Ther; 1998 Sep 26; 12(9):881-5. PubMed ID: 9768531 [Abstract] [Full Text] [Related]
10. Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study. Luzza F, Giglio A, Ciliberto E, Belmonte A, Cavaliere C, Saccà N, Frandina C, Fiocca R, Trimboli V, Pallone F. Clin Ther; 2001 May 26; 23(5):761-70. PubMed ID: 11394734 [Abstract] [Full Text] [Related]
11. Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. GISU (Interdisciplinary Group for Ulcer Study). Di Mario F, Battaglia F, Dal Bò N, Leandro G, Benedetti E, Bottona E, Caroli A, Costan-Biedo F, De Bastiani R, Germanà B, Andrea Grassi S, Madia D, Marcon V, Marin R, Monica F, Olivieri P, Orzes N, Pilotto A, Ronzani G, Saggioro A, Tafner G. Dig Liver Dis; 2000 Mar 26; 32(2):108-15. PubMed ID: 10975783 [Abstract] [Full Text] [Related]
12. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. Schwartz H, Krause R, Sahba B, Haber M, Weissfeld A, Rose P, Siepman N, Freston J. Am J Gastroenterol; 1998 Apr 26; 93(4):584-90. PubMed ID: 9576452 [Abstract] [Full Text] [Related]
13. Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients. Pilotto A, Franceschi M, Leandro G, Bozzola L, Fortunato A, Rassu M, Meli S, Soffiati G, Scagnelli M, Di Mario F, Valerio G. J Gastroenterol Hepatol; 1999 May 26; 14(5):468-75. PubMed ID: 10355512 [Abstract] [Full Text] [Related]
14. Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection. Spinzi GC, Bierti L, Bortoli A, Colombo E, Fertitta AM, Lanzi GL, Venturelli R, Minoli G. Aliment Pharmacol Ther; 1998 May 26; 12(5):433-8. PubMed ID: 9663722 [Abstract] [Full Text] [Related]
15. Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country. Ahuja V, Dhar A, Bal C, Sharma MP. Aliment Pharmacol Ther; 1998 Jun 26; 12(6):551-5. PubMed ID: 9678815 [Abstract] [Full Text] [Related]
16. Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide. Hahm KB, Lee KJ, Kim YS, Kim JH, Cho SW, Yim H, Joo HJ. Dig Dis Sci; 1998 Feb 26; 43(2):235-40. PubMed ID: 9512112 [Abstract] [Full Text] [Related]
17. Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pylori. Ammon S, Treiber G, Kees F, Klotz U. Aliment Pharmacol Ther; 2000 Jun 26; 14(6):759-66. PubMed ID: 10848660 [Abstract] [Full Text] [Related]
19. Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer. Catalano F, Catanzaro R, Bentivegna C, Brogna A, Condorelli G, Cipolla R. Aliment Pharmacol Ther; 1998 Jan 26; 12(1):59-62. PubMed ID: 9692702 [Abstract] [Full Text] [Related]